Pharmacotherapy for Beh çet’s Disease and the Risk of Malignancy

Conclusion: Our study revealed that CYC was associated with a high risk of cancer in BD patients. Furthermore, C4 and Hb are independent protective factors for oncogenesis in BD patients. These findings may provide references and suggestions for clinicians to select appropriate treatments and for the early recognition of high-risk patients to reduce cancer incidence in BD patients.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research